Àڱøñ¾ÏÁ¾¿¡¼ Tetranucleotide Repeat Microsatellite Instability¿¡ °üÇÑ ¿¬±¸
Tetranucleotide Repeat Microsatellite Instability in Uterine Cervical Carcinomas
ÃÖÀ¯´ö, ÀÌÁö½Å, ÃÖÂù, ¹Úâ¼ö, Á¤»ó¿ì, ³²Á¾Èñ, ÃÖÈ£¼±,
¼Ò¼Ó »ó¼¼Á¤º¸
ÃÖÀ¯´ö ( Choi Yoo-Duk )
Àü³²´ëÇб³ ÀÇ°ú´ëÇÐ º´¸®Çб³½Ç
ÀÌÁö½Å ( Lee Ji-Shin )
Àü³²´ëÇб³ ÀÇ°ú´ëÇÐ º´¸®Çб³½Ç
ÃÖÂù ( Choi Chan )
Àü³²´ëÇб³ ÀÇ°ú´ëÇÐ º´¸®Çб³½Ç
¹Úâ¼ö ( Park Chang-Soo )
Àü³²´ëÇб³ ÀÇ°ú´ëÇÐ º´¸®Çб³½Ç
Á¤»ó¿ì ( Juhng Sang-Woo )
Àü³²´ëÇб³ ÀÇ°ú´ëÇÐ º´¸®Çб³½Ç
³²Á¾Èñ ( Nam Jong-Hee )
Àü³²´ëÇб³ ÀÇ°ú´ëÇÐ º´¸®Çб³½Ç
ÃÖÈ£¼± ( Choi Ho-Sun )
Àü³²´ëÇб³ ÀÇ°ú´ëÇÐ »êºÎÀΰúÇб³½Ç
KMID : 0357920070410010030
Abstract
Background : Elevated levels of microsatellite alterations at selected tetranucleotide repeat regions (EMAST) have been recently described, and they are a distinct type of microsatellite instability (MSI). We investigated the prevalence of EMAST in squamous cell carcinoma (SCC) of the uterine cervix and we determined the correlation between EMAST and the clinicopathologic parameters, HPV infection and the p53 mutation.
Methods : We examined the 3 mono-, 3 di-, and 5 tetranucleotide repeat markers in 47 cases of SCC, and we performed immunohistochemical staining for p53. HPV detection and genotyping was performed using a commercially available HPV DNA chip.
Results : Thirteen out of 47 cases (27.7%) were EMAST(+) with at least one of five tetranucleotide repeat markers. However, MSI at mono- and dinucleo- tide markers was noted in only one case (2.1%). EMAST was not related with stage, size, lymph node metastasis, vascular/lymphatic invasion or the depth of invasion. Positive immunostaining for p53 was significantly more common in EMAST(+) tumors than in the EMAST(-) tumors (p=0.04). HPV-infection was positive in 32 cases. EMAST was not correlated with the state of HPV infection state or the HPV genotype.
Conclusions : 27.7% of the invasive SCCs of the uterine cervix exhibited EMAST, and EMAST in the SCC of the uterine cervix was significantly associated with the p53 mutation.
Å°¿öµå
Cervix; Squamous cell carcinoma; Microsatellite instability; Human papillomavirus; p53
¿ø¹® ¹× ¸µÅ©¾Æ¿ô Á¤º¸
µîÀçÀú³Î Á¤º¸